Management of Acute Porphyria Attacks
Introduction to Porphyria
- Porphyrias are rare inherited disorders of heme biosynthesis caused by specific enzyme deficiencies in the heme pathway, classified into two main categories: acute hepatic porphyrias and cutaneous porphyrias 3, 4
Acute Attack Management
- The management of acute porphyria attacks requires immediate intravenous hemin administration at 3-4 mg/kg body weight daily for typically 4 days, preferably into a high-flow central vein, along with aggressive pain control, antiemetics, and management of electrolyte abnormalities 1, 2
- Intravenous hemin therapy is the cornerstone of treatment for acute attacks requiring hospitalization, with a dosage of 3-4 mg/kg body weight once daily, typically for 4 days, and administration preferably into a high-flow central vein via a peripherally inserted central catheter or central port 1, 2
- Aggressive pain management with appropriate analgesics, antiemetics for nausea and vomiting, and intravenous carbohydrate loading are also recommended 1, 5
Prevention of Acute Attacks
- Identify and eliminate precipitating factors, including medications that induce cytochrome P450, alcohol consumption, hormonal fluctuations, physical or psychological stress, fasting or caloric deprivation, and infections or acute illnesses 6, 7
- Consult drug safety databases for porphyria to ensure safe medication use 6, 8
Prophylactic Treatment for Recurrent Attacks
- For patients with 4 or more attacks per year, consider prophylactic therapy, including scheduled intravenous hemin infusions or subcutaneous givosiran (RNA interference therapy targeting ALAS1) 8, 4
- For women with menstrual cycle-associated attacks, consider hormonal suppression therapy (GnRH agonists) 8
Long-Term Monitoring
- Regular monitoring for complications, including hepatocellular carcinoma, chronic renal disease, hypertension, and chronic neuropathy 2, 9